Your session is about to expire
← Back to Search
Transcranial Magnetic Stimulation for Bipolar Disorder
Study Summary
This trial is testing if transcranial magnetic stimulation can help people with bipolar disorder regulate their emotions better.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have never been diagnosed with a mental health disorder after being assessed with the MINI.I am between 18 and 55 years old.Your ability to manage and control your emotions will be assessed using a scale called the DERS. If you score less than 80 on this scale, it means that you have normal levels of emotion regulation.Requirements for people who are healthy and will be used as a comparison group in the study.
- Group 1: Bipolar Group
- Group 2: Healthy Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any unfilled vacancies available to join this clinical trial?
"Affirmative. Per the information recorded on clinicaltrials.gov, this research initiative is currently looking for participants. Initially posted on March 1st 2021, with subsequent updates made on May 3rd of 2022, 60 patients are being sought out from a single centre."
Is the age criterion for this experiment limited to individuals over 25 years old?
"As indicated by the inclusion criteria, this medical trial is limited to participants aged 22 and 55. For individuals below 18 years old or over 65 there are 35 trials available and 151 respective options respectively."
How many individuals are being included in this experiment?
"Affirmative. The clinicaltrials.gov database shows that this trial is currently recruiting participants–it was first uploaded on March 1st 2021 and its latest update occurred on May 3rd 2022. This study requires 60 individuals at a single medical facility to be recruited for participation."
Are there any opportunities for me to join this experiment?
"This medical trial is enrolling 60 individuals aged between 22 and 55 who have been diagnosed with manic disorder. Besides this, potential participants should be male or female adults over the age of 18 without any history of psychiatric conditions as determined by the Mini-International Neuropsychiatric Interview (MINI). Furthermore, applicants must present nonclinical levels of emotion dysregulation based on their score in the Difficulties in Emotion Regulation Scale (DERS), which will be defined as a score below 80."
What objectives are the researchers hoping to achieve with this clinical endeavor?
"The main objective of this trial, which will be monitored across a Change from Baseline to Post-TMS Stimulation (30 min-1 hour) period is the evaluation of Multisource Interference Task with International Affective Pictures Set (MSIT-IAPS). Supplementary metrics include Skin Conductance Response - recording electrodermal skin response via electrodes sensors on fingertips., ECR Task-induced blood oxygen level dependent (BOLD) signal tracking task performance and distress ratings during Cognitive Reappraisal tasks., as well as MSIT-IAPS Task-induced blood oxygen level dependent (BOLD) signal noting differences between CI versus"
Share this study with friends
Copy Link
Messenger